Rolziracetam
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
| |
Synonyms | 2,6,7,8-tetrahydro-1H-pyrrolizine-3,5-dione |
CAS Number | 18356-28-0 |
PubChem (CID) | 71893 |
ChemSpider | 64906 |
UNII | RES9I0LGG5 |
ChEMBL | CHEMBL51396 |
Chemical and physical data | |
Formula | C7H9N2O2 |
Molar mass | 139.152 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Rolziracetam is a nootropic drug of the racetam family.
Rolziracetam was found to improve performance on a delayed-response task in aged rhesus monkeys. It has a wide margin of safety in animals and has been evaluated for use in cognitively impaired human subjects. [1]
See also
References
- ↑ Butler DE, Leonard JD, Caprathe BW, L'Italien YJ, Pavia MR, Hershenson FM, Poschel PH, Marriott JG. Amnesia-reversal activity of a series of cyclic imides. Journal of Medicinal Chemistry. 1987 Mar;30(3):498-503.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.